This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2010 Remove Food and Drug Administration Remove Healthcare Remove Leads
article thumbnail

Beyond overall survival: Time to agree on the value of alternative oncology endpoints?

Clarivate

MAY 21, 2024

Major barriers to the broader adoption of alternative oncology-relevant endpoints in clinical trials include a lack of agreement on their value and the uncertainty among payers that they accurately capture treatment benefits for patients and healthcare systems [4] [6]. Oncologist, 2010. Am J Cancer Res, 2021. 1121-1131. [2]

Food and Drug Administration 52
Food and Drug Administration Patients Consulting Marketing 52
article thumbnail

Three biggest threats to healthcare

World of DTC Marketing

APRIL 7, 2022

Right now, voters are worried about inflation and rising fuel prices, but they ignore the imminent threats to their healthcare. American healthcare continues to be under assault, and unless we address these issues, a severe health issue could bankrupt families. THREAT 3: RISING HEALTHCARE COSTS. THREAT 1: OBESITY AND DIABETES.

Healthcare 215
Healthcare Healthcare Food and Drug Administration Government 215
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024